Geneva/Yokohama, 26 August 2025 – Gavi, the Vaccine Alliance welcomed renewed commitments to health equity in Africa made at the Ninth Tokyo International Conference on African Development (TICAD9), held in Yokohama from 20–22 August 2025, which demonstrated Japan’s strong commitment to co-creating innovative solutions for Africa’s health equity.
At the Opening Session of TICAD9, H.E. Shigeru Ishiba, Prime Minister of Japan announced Japan’s commitment to Gavi, noting: “We will support Africa’s vaccine supply through contributions of up to $550 million over the next five years to Gavi, the Vaccine Alliance.”
This contribution to Gavi’s next strategic period from 2026 to 2030 (Gavi 6.0), underscores Japan’s unwavering leadership in global health as well as its dedication to advancing vaccine delivery and health equity on the African continent through co-created solutions. It also underscores the importance of health in relation to national and global security. With 80% of Gavi’s investments directed to Africa, Japan’s support will be pivotal in helping Gavi achieve its goal of protecting more children against more diseases, faster than ever before by 2030, when Japan will host the G7 presidency.
Gavi and the African Union Commission (AUC) also convened a TICAD9 Official Thematic Event titled “Co-creating Africa’s Innovative Solutions on Immunization as a Cornerstone of Universal Health Coverage (UHC) by 2030.” The event focused on advancing immunisation, scaling up domestic health financing, and building sustainable vaccine manufacturing capacity on the African continent. Building on the Addis Ababa Declaration on Immunization (ADI), participants stressed that the centrality of Africa’s leadership in health development was critical to progress and impact – issuing a call for stronger political and financial ownership by African governments, and for multilateral and bilateral partners to meaningfully support these efforts. The co-hosts also agreed to build on the strategic momentum created by Gavi’s African Vaccine Manufacturing Accelerator (AVMA), which is backed by a contribution of US$ 30 million from Japan, and collaborate in support of the AU’s vision for regional manufacturing.
“Africa’s purpose is to protect every child, nurture every community and secure the wellbeing of generations to come,” said H.E. Amb. Amma Twum-Amoah, Commissioner for Health, Humanitarian Affairs and Social Development, African Union Commission. “This can be achieved through longstanding partnership and steadfast commitment towards health equity and access to immunisation. Gavi, the Vaccine Alliance and the Government of Japan have made clear commitment to such a foundation on Universal Health Coverage.”
Noting the remarkable progress made across the African region – which has successfully raised immunisation coverage to pre-COVID-19 pandemic levels despite an increasing birth cohort – partners agreed that continued efforts to reach unimmunised children across the African continent, particularly the 8.3 million “zero-dose” children who have yet to receive a basic vaccine, will be critical. Investing in strengthening country-led health systems and innovative finance approaches such as debt buy-downs will also be important to sustaining immunisation progress and strengthening health security.
“The progress made so far is a testament to steadfast political and financial commitment from countries and donors, who have continued to prioritise immunisation as one of the best investments to be made in health, development and security. We are deeply grateful to our host the Government of Japan for the announcement of their pledge in support of Gavi’s next strategic period,” said Dr Sania Nishtar, CEO of Gavi. “Through our ambitious Gavi Leap agenda we are working hard to ensure country ownership and countries’ priorities are at the heart of strategy and decision making, and I thank the African Union Commission and Japan for their on-going partnership.”
Since 2000, more than 469 million children have been immunised – with more than 12 million deaths averted – through the strong partnership between Gavi and African governments. Through its innovative co-financing model Gavi focuses on country ownership and self-sufficiency, with countries implementing Gavi programmes contributing record amounts towards their own immunisation programmes. Through steadily increased domestic financing of vaccine programmes combined with Gavi investments in health systems, countries are eventually able to self-finance immunisation. During Gavi's next strategic period (2026–2030), and as part of a transformative agenda to further place countries in the driver’s seat called the Gavi Leap, the organisation will leverage new ways of working – from partnerships to technologies and innovative financing – to strengthen health systems and improve delivery at the last mile.
All participants emphasised that co-creating innovative financial and technological solutions to build health systems that leave no one behind – and can detect, respond, contain and remain resilient in the face of infectious disease threats – is critical to Africa’s health development as well as global health security. For example, participants highlighted innovations introduced in Africa that could be leveraged to address challenges Japan currently faces, with Gavi serving as a critical connector between partners. The Government of Japan has taken a leading role in promoting universal health coverage (UHC) and human security as the overarching approach for attaining Sustainable Development Goal 3, including as a key Gavi donor and AUC partner.
“I had the opportunity to visit an operation site of Gavi in Ghana last year and realised that support for Africa’s health sector has a potential to improve lives and to drive societal change,” said H.E. Hisayuki Fujii, State Minister of Foreign Affairs, Japan. “As the Prime Minister Ishiba announced at the Opening Session of TICAD 9, Japan will contribute up to $550 million to Gavi for the next five years. We are proud to strongly support Gavi in ensuring the success of its next strategic plan.”
Meg Sharafudeen
+41 79 711 55 54
msharafudeen@gavi.org
Cirũ Kariũki
+41 79 913 94 41
ckariuki@gavi.org
Laura Shevlin
41 79 529 92 87
lshevlin@gavi.org
Collins Weru Mwai
+25 078 783 66 38
cmwai@gavi.org
Eunice Kilonzo-Muraya
+41 76 424 85 03
ekilonzo@gavi.org